Glioma Stem Cells Upregulate CD39 Expression to Escape Immune Response through SOX2 Modulation

SIMPLE SUMMARY: Glioblastoma is the most malignant tumor of the central nervous system. Glioma stem cells are the cause of adverse outcomes such as early recurrence and low overall survival in glioma patients. Targeting glioma stem cells is considered a promising anti-glioma strategy, Although CD39...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bin, Cao, Yufei, Li, Yanyan, Ma, Haifeng, Yang, Mingfei, Zhang, Qiang, Li, Guofeng, Zhang, Kai, Wu, Yue, Zhou, Youxin, Yang, Wei, Sun, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834269/
https://www.ncbi.nlm.nih.gov/pubmed/35159053
http://dx.doi.org/10.3390/cancers14030783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834269/
https://www.ncbi.nlm.nih.gov/pubmed/35159053
http://dx.doi.org/10.3390/cancers14030783

Ejemplares similares